^
NTRK1 fusion
Spindle Cell Sarcoma
entrectinib
Sensitive: C1 - Off-label
NTRK3 fusion
Spindle Cell Sarcoma
entrectinib
Sensitive: C1 - Off-label
KRAS G12V
Spindle Cell Sarcoma
BAL3833
Sensitive: C3 – Early Trials
SMARCB1 negative
Spindle Cell Sarcoma
tazemetostat
Sensitive: C3 – Early Trials
TPM3-NTRK1 fusion
Spindle Cell Sarcoma
larotrectinib
Sensitive: C4 – Case Studies
KIAA1549-BRAF fusion + PTEN deletion
Spindle Cell Sarcoma
bevacizumab + sorafenib + temsirolimus
Sensitive: C4 – Case Studies